Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 1, 2006, Pages 31-35

  Jawa, A ^a   Nachimuthu, S ^b   Pendergrass, M ^c   Asnani, S ^a   Fonseca, V ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Huey P Long Medical Center   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC NEPHROPATHY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDOTHELIUM LESION; FEMALE; HUMAN; MALE; MICROALBUMINURIA; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RACE DIFFERENCE;

ADULT; AFRICAN AMERICANS; AGED; ALBUMINURIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRACHIAL ARTERY; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NITROGLYCERIN; PROTEINURIA; ULTRASONICS; VASODILATION; VASODILATOR AGENTS;

EID: 30344442447     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1632     Document Type: Article

References (37)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D 1993 Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444
2. Kannel WB, McGee DL 1979 Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120-126
3. Carter JS, Pugh JA, Monterrosa A 1996 Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 125:221-232
4. Krop JS, Coresh J, Chambless LE 1999 A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 159:1777-1783
5. Fonseca V, Desouza C, Asnani S, Jialal I 2004 Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev 25:153-175
6. Raitakari OT, Celermajer DS 2000 Flow-mediated dilatation. Br J Clin Pharmacol 50:397-404
7. Cooke JP, Dzau VJ 1997 Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 96:379-382
8. Ross R 1999 Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
9. Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT 1996 Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45:1253-1258
10. John S, Schmieder RE 2000 Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens 18:363-374
11. Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ 2003 Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med 20:277-282
12. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP 1989 Renal insufficiency in treated essential hypertension. N Engl J Med 320:684-688
13. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD 1992 Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 268:3085-3091
14. Lea J, Greene T, Hebert L 2005 The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med 165:947-953
15. Cardillo C, Kilcoyne CM, Cannon III RO, Panza JA 1999 Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation 99:90-95
16. Jones D, Basile J, Cushman W 1999 Managing hypertension in the south-eastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci 318:357-364
17. Perregaux D, Chaudhuri A, Rao S 2000 Brachial vascular reactivity in blacks. Hypertension 36:866-871
18. Rahman M, Pressel S, Davis BR 2005 Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 165:936-946
19. Corretti MC, Anderson TJ, Benjamin EJ 2002 Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265
20. Taylor AJ, Merz CN, Udelson JE 2003 34th Bethesda Conference: executive summary - can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J Am Coll Cardiol 41:1860-1862
21. Jones DS, Andrawis NS, Abemethy DR 1999 Impaired endothelial-dependent forearm vascular relaxation in black Americans. Clin Pharmacol Ther 65:408-412
22. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robin-son J, Deanfield JE 1994 Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24:471-476
23. Marchesi S, Lupattelli G, Schillaci G 2000 Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis 153:397-402
24. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD 1996 Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610
25. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA 1989 Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025-1030
26. Ghiadoni L, Taddei S, Virdis A 1998 Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 32:25-32
27. Srinivasan SR, Myers L, Berenson GS 2000 Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study. Am J Hypertens 13:1274-1279
28. Papaioannou GI, Seip RL, Grey NJ 2004 Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol 94:294-299
29. Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ 1998 Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 339:1285-1292
30. Levy SB, Lilley JJ, Frigon RP, Stone RA 1977 Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest 60:129-138
31. Gainer JV, Nadeau JH, Ryder D, Brown NJ 1996 Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol 98:283-287
32. Taylor AL, Ziesche S, Yancy C 2004 Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351:2049-2057
33. Bloche MG 2004 Race-based therapeutics. N Engl J Med 351:2035-2037
34. Winkleby MA, Kraemer HC, Ahn DK, Varady AN 1998 Ethnic and socio-economic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 280:356-362
35. Winkleby MA, Robinson TN, Sundquist J, Kraemer HC 1999 Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 281:1006-1013
36. Falkner B, Sherif K, Sumner AE, Kushner H 1999 Blood pressure increase with impaired glucose tolerance in young adult American blacks. Hypertension 34:1086-1090
37. Doherty TM, Tang W, Detrano RC 1999 Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors. J Am Coll Cardiol 34:787-794